Corcept Therapeutics Inc CORT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 07/01/22 EDT
25.44UNCH (UNCH)
Volume
24,470
Close
25.44quote price arrow up+1.66 (+6.98%)
Volume
868,370
52 week range
15.82 - 25.68
Loading...
  • Open23.94
  • Day High25.59
  • Day Low23.93
  • Prev Close23.78
  • 52 Week High25.68
  • 52 Week High Date04/14/22
  • 52 Week Low15.82
  • 52 Week Low Date12/08/21

Key Stats

  • Market Cap2.703B
  • Shares Out106.25M
  • 10 Day Average Volume0.78M
  • Dividend-
  • Dividend Yield-
  • Beta0.43
  • YTD % Change28.48

KEY STATS

  • Open23.94
  • Day High25.59
  • Day Low23.93
  • Prev Close23.78
  • 52 Week High25.68
  • 52 Week High Date04/14/22
  • 52 Week Low15.82
  • 52 Week Low Date12/08/21
  • Market Cap2.703B
  • Shares Out106.25M
  • 10 Day Average Volume0.78M
  • Dividend-
  • Dividend Yield-
  • Beta0.43
  • YTD % Change28.48

RATIOS/PROFITABILITY

  • EPS (TTM)0.91
  • P/E (TTM)27.86
  • Fwd P/E (NTM)25.09
  • EBITDA (TTM)132.714M
  • ROE (TTM)24.35%
  • Revenue (TTM)380.23M
  • Gross Margin (TTM)98.62%
  • Net Margin (TTM)29.41%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date07/27/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Corcept Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Corcept Therapeutics Incorporated is a commercial-stage company engaged in the discovery and development of drugs that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effects of the hormone cortisol. The Company operates through the discovery, development and commercialization of the pharmaceutical products segment. It has marketed Korlym (mifepristone) for the treatment of patients suffering from Cushing’s syndrome. The Company’s portfolio...
James Wilson
Independent Chairman of the Board
Joseph Belanoff M.D.
President, Chief Executive Officer, Co-Founder, Director
Atabak Mokari
Chief Financial Officer, Treasurer
Joseph Lyon
Chief Accounting Officer
Address
149 Commonwealth Dr
Menlo Park, CA
94025
United States

Top Peers

SYMBOLLASTCHG%CHG
PCRX
Pacira Biosciences Inc
57.85-0.45-0.77%
HRMY
Harmony Biosciences Holdings Inc
52.00+3.23+6.62%
IRWD
Ironwood Pharmaceuticals Inc
11.53UNCHUNCH
AMPH
Amphastar Pharmaceuticals Inc
35.35+0.56+1.61%
TVTX
Travere Therapeutics Inc
25.09+0.86+3.55%